International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.
Clinical and translational science
Effects of Renal Impairment on the Pharmacokinetics of Gefapixant, a P2X3 Receptor Antagonist.
Journal of clinical pharmacology
A Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of 3 Weeks of Orally Administered Gefapixant in Healthy Younger and Older Adults.